SciSparc Ltd.
SPRC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001611746
No open-market purchases or sales by SciSparc Ltd. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $296.4K in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding SciSparc Ltd. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 5 | 7 | +2 |
| Shares | 138.5K | 473.4K | +334.9K (+241.8%) |
| Value | $530.0K | $1.01M | +$477.0K (+90.0%) |
New holders (3)
Institutions that held SciSparc Ltd. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 335,000 | $714.0K | 0.02% |
| Citadel Advisors LLC | 19,807 | $41.0K | 0.00% |
| Citigroup Inc | 50 | $0 | 0.00% |
Sold out (1)
Institutions that held SciSparc Ltd. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Virtu Financial LLC | 16,261 | $62.0K |